Aspilia paludosa
Aspilia paludosa · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Aspilia paludosa is a medicinal plant recognized for its significant pharmacological potential in addressing various health conditions. Research involving its methanolic extracts and various fractions has demonstrated potent antimalarial, antinociceptive, and antioxidant activities. These biological effects are largely attributed to key chemical constituents such as kaurenoic acid, coumarins, stigmasterol, and luteolin. Studies suggest that these bioactive compounds may play a crucial role in regulating blood glucose levels and combating malaria. Consequently, the plant serves as a valuable subject for exploring natural therapeutic strategies against these complex diseases.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Asia-Temperate
- Plant Parts
- Not available
Classification
Taxonomy
Aspilia paludosa is a distinct botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, it is classified under the class Equisetopsida. It further belongs to the order Asterales, showcasing its specific evolutionary lineage. This plant is a member of the diverse family Asteraceae, which is well-known for its complex floral structures. Ultimately, it is categorized under the genus Aspilia, defining its unique identity among its relatives.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Aspilia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Aspilia paludosa is a plant species widely distributed across the diverse landscapes of the African continent. Within Northeast Tropical Africa, it can be found established in the regions of Chad. Its presence extends significantly into West Tropical Africa, where it inhabits several key territories. Specifically, this species is documented growing throughout Burkina, Guinea, and Mali. Furthermore, its range continues through the nation of Senegal, showcasing a broad geographical footprint.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Aspilia paludosa is a self-supporting herb characterized by its sturdy growth form. This plant typically reaches a maximum height of approximately 1.22 meters. Its structural integrity allows it to stand upright within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Aspilia paludosa, also known as Wedelia paludosa, demonstrates a diverse range of pharmacological properties that highlight its medicinal potential. Research indicates that ent-kaurane diterpenes derived from this plant exhibit significant antimalarial activity by targeting the PfATP6 protein in Plasmodium falciparum. Additionally, the plant possesses notable antinociceptive effects, with specific constituents like kaurenoic acid and luteolin performing even more effectively than common analgesics in certain models. Its chemical profile also reveals a high concentration of phenolic compounds, which contribute to substantial antioxidant power. Together, these biological activities suggest that the plant is a rich source of bioactive compounds for drug development.
Compounds
Aspilia paludosa, also referred to in studies as Wedelia paludosa, possesses a complex phytochemical profile that contributes to its traditional medicinal uses. Scientific analysis has confirmed that the plant contains kaurenoic acid and stigmasterol, both of which are detected across various extracts. Additionally, the species contains luteolin, though this specific compound is found primarily in smaller quantities within the leaves and stems. Phytochemical screening has also identified the presence of coumarins within the plant's aqueous extracts. Together, these diverse chemical constituents support the plant's established role in treating various painful and algesic processes.
Conditions
Aspilia paludosa, also referred to as Wedelia paludosa, demonstrates significant therapeutic potential through several medicinal properties. Research indicates that its diterpene compounds can target PfATP6 to treat malaria by disrupting parasite calcium homeostasis. The plant also exhibits marked antinociceptive effects, specifically helping to treat acetic acid-induced writhing in animal models. Furthermore, its extracts have been shown to significantly lower blood glucose levels in diabetic subjects. These hypoglycemic properties suggest that the plant can effectively serve as a treatment for diabetes.
Preparations
Aspilia paludosa is prepared as an extract to evaluate its hypoglycemic effects in diabetic models. This plant is also prepared as fractions to isolate specific chemical constituents responsible for antinociceptive activity. Furthermore, Aspilia paludosa is prepared as methanolic extracts from various plant parts to analyze their phytochemical profiles. These different preparation methods, including the use of extracts and fractions, allow for the study of its therapeutic potential. The diverse ways in which the plant is prepared facilitate the identification of active compounds like kaurenoic acid and luteolin.